Back | Next |
home / stock / rdgl / rdgl message board
Subject | By | Source | When |
---|---|---|---|
WALLnut, you are the most realistic on here. | PioneerEmpire67 | investorshub | 07/02/2024 1:33:31 AM |
I hear ya Bro. Not giving up, just | WALLnut | investorshub | 07/02/2024 1:27:04 AM |
Nope, not creating clouds. But good to know | WALLnut | investorshub | 07/02/2024 1:11:11 AM |
Wish the offering had been at a more | Three2001 | investorshub | 07/02/2024 12:24:51 AM |
After FDA approval, Vivos will become a very | mikepgator | investorshub | 07/02/2024 12:23:58 AM |
interesting.. seems pertinent to the action here | SparksEE | investorshub | 07/02/2024 12:03:22 AM |
Wallnut, weve both been here a very long | CatfishHunter | investorshub | 07/02/2024 12:02:41 AM |
Its the OTC once they saw the word | wrinklesobw | investorshub | 07/01/2024 11:43:09 PM |
There is no chips falling anywhere and MMs | WhAtEvA1 | investorshub | 07/01/2024 11:38:49 PM |
It should be frustrating to us all. | WALLnut | investorshub | 07/01/2024 11:20:55 PM |
https://www.biopharmadive.com/news/eli-lilly-point-biopharma-radiopharmaceutical | classics99 | investorshub | 07/01/2024 11:14:26 PM |
The pps isn't on schedule. Or at lease | WALLnut | investorshub | 07/01/2024 11:14:21 PM |
It frustrates some shareholders . | Roofus | investorshub | 07/01/2024 11:06:28 PM |
Last 5 out of 6 days red on | WALLnut | investorshub | 07/01/2024 10:54:13 PM |
Do you know who these company are? How | WALLnut | investorshub | 07/01/2024 10:46:55 PM |
Agree, its amazing how much doom and gloom | wrinklesobw | investorshub | 07/01/2024 10:44:36 PM |
No agenda...... Of course dude! | WhAtEvA1 | investorshub | 07/01/2024 10:42:35 PM |
100% | SparksEE | investorshub | 07/01/2024 10:36:27 PM |
You all need to chill the F out. | Grig81 | investorshub | 07/01/2024 10:18:02 PM |
Do your usual math. If x amount of | AtlasQ | investorshub | 07/01/2024 10:13:44 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...